+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

From
Gestational Diabetes Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Gestational Diabetes Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 192 Pages
  • Global
From
Insulin Pens Market Report and Forecast 2023-2031 - Product Thumbnail Image

Insulin Pens Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
United Arab Emirates Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Thumbnail Image

United Arab Emirates Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • March 2025
  • 50 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more